ARS Pharmaceuticals, Inc. financial data

Symbol
SPRY on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 10 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 853% % -71.7%
Quick Ratio 41.6% %
Debt-to-equity 65.3% % 1828%
Return On Equity -38.8% % -71.9%
Return On Assets -23.5% % -7.52%
Operating Margin -63.6% % 97.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 98,848,611 shares 1.71%
Common Stock, Shares, Outstanding 98,844,178 shares 1.75%
Entity Public Float $466,100,000 USD 22.1%
Common Stock, Value, Issued $10,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 98,807,600 shares 1.83%
Weighted Average Number of Shares Outstanding, Diluted 98,807,600 shares 1.83%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $142,772,000 USD 5460%
Research and Development Expense $12,765,000 USD -36%
General and Administrative Expense $38,700,000 USD -1.14%
Operating Income (Loss) $-90,786,000 USD -50%
Net Income (Loss) Attributable to Parent $-80,040,000 USD -63%
Earnings Per Share, Basic 0 USD/shares -58.8%
Earnings Per Share, Diluted 0 USD/shares -58.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $59,557,000 USD 50.2%
Accounts Receivable, after Allowance for Credit Loss, Current $36,451,000 USD 4616%
Inventory, Net $21,427,000 USD 2897%
Assets, Current $338,863,000 USD 62.3%
Property, Plant and Equipment, Net $1,209,000 USD 43.4%
Operating Lease, Right-of-Use Asset $1,439,000 USD 1464%
Intangible Assets, Net (Excluding Goodwill) $14,729,000 USD 96.4%
Assets $372,803,000 USD 71.3%
Accounts Payable, Current $8,382,000 USD 1.28%
Employee-related Liabilities, Current $5,448,000 USD
Contract with Customer, Liability, Current $526,000 USD
Liabilities, Current $50,877,000 USD 206%
Contract with Customer, Liability, Noncurrent $1,268,000 USD
Operating Lease, Liability, Noncurrent $949,000 USD
Liabilities $225,148,000 USD 1254%
Accumulated Other Comprehensive Income (Loss), Net of Tax $-7,000 USD -102%
Retained Earnings (Accumulated Deficit) $-253,279,000 USD -46.2%
Stockholders' Equity Attributable to Parent $147,655,000 USD -26.5%
Liabilities and Equity $372,803,000 USD 71.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-40,742,000 USD -507%
Net Cash Provided by (Used in) Financing Activities $725,000 USD 181%
Net Cash Provided by (Used in) Investing Activities $29,064,000 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 98,844,178 shares 1.75%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $-10,953,000 USD 26.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $59,557,000 USD 50.2%
Deferred Tax Assets, Valuation Allowance $36,863,000 USD 26.9%
Deferred Tax Assets, Gross $36,863,000 USD 26.9%
Operating Lease, Liability $1,532,000 USD 1402%
Depreciation $11,000 USD -45%
Payments to Acquire Property, Plant, and Equipment $91,000 USD 9.64%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $-80,386,000 USD -65.4%
Lessee, Operating Lease, Liability, to be Paid $1,854,000 USD 1683%
Property, Plant and Equipment, Gross $748,000 USD 14.7%
Operating Lease, Liability, Current $583,000 USD 472%
Lessee, Operating Lease, Liability, to be Paid, Year Two $627,000 USD 1393%
Lessee, Operating Lease, Liability, to be Paid, Year One $609,000 USD 882%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $322,000 USD 16000%
Lessee, Operating Lease, Liability, to be Paid, Year Three $318,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $12,834,000 USD -20.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $7,028,000 USD 139%
Operating Lease, Payments $141,000 USD 127%
Additional Paid in Capital $400,931,000 USD 7.24%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $300 USD
Deferred Tax Assets, Net of Valuation Allowance $37,001,000 USD 26.9%
Share-based Payment Arrangement, Expense $14,534,000 USD 57.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%